{
  "documentInfo": {
    "title": "TUH-Inc. Empiric Antimicrobial Therapy Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH-Inc.",
    "versionDate": "2025-04-02",
    "sourceFile": "ATTCHMENT A_Inpatient Empiric antimicrobial Recommendations for common infections_ver 2025-04-02_shared with ED.docx"
  },
  "infections": [
    {
      "id": "intra_abdominal_infection",
      "name": "Intra-abdominal Infection",
      "diagnostics": null,
      "pathways": [
        {
          "label": "Community Acquired Intra-abdominal Infection",
          "eligibilityCriteria": {
            "setting": "Community-Acquired"
          },
          "duration": {
            "minDays": 4,
            "maxDays": 4,
            "notes": [
              "Duration is 4 days after adequate source control."
            ]
          },
          "consults": [
            "ID consult recommended in patients who are hemodynamically unstable or have difficult to achieve source control."
          ],
          "treatmentRecommendations": [
            {
              "allergyProfile": ["none", "pcn_mild_rash"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [
                    {
                      "name": "ceftriaxone",
                      "routes": ["IV"],
                      "variants": [
                        {
                          "label": "Standard dose",
                          "dosingByRenalFunction": [
                            {"renalCategory": "gt_50", "dose": "1-2g", "frequency": "q24h"},
                            {"renalCategory": "50_30", "dose": "1-2g", "frequency": "q24h"},
                            {"renalCategory": "29_10", "dose": "1-2g", "frequency": "q24h"},
                            {"renalCategory": "lt_10_no_hd", "dose": "1-2g", "frequency": "q24h"},
                            {"renalCategory": "hd", "dose": "1-2g", "frequency": "q24h AD"},
                            {"renalCategory": "crrt", "dose": "2g", "frequency": "q24h", "dataQuality": {"renalBin": "limited"}}
                          ]
                        }
                      ]
                    },
                    {
                      "name": "metronidazole",
                      "routes": ["IV", "PO"],
                      "variants": [
                        {"label": "General anaerobic", "dose": "500mg", "frequency": "q12h"},
                        {"label": "C. difficile/CNS", "dose": "500mg", "frequency": "q8h"}
                      ]
                    }
                  ]
                },
                {
                  "rank": 2,
                  "primaryDrugs": [
                    {
                      "name": "piperacillin-tazobactam",
                      "routes": ["IV"],
                      "variants": [
                        {
                          "label": "Extended infusion",
                          "loadingDose": {"dose": "4.5gm", "infuseMinutes": 30},
                          "infusion": {"type": "extended", "infuseMinutes": 240},
                          "dosingByRenalFunction": [
                            {"renalCategory": "gt_50", "dose": "3.375g", "frequency": "q8h"},
                            {"renalCategory": "50_30", "dose": "3.375g", "frequency": "q8h"},
                            {"renalCategory": "29_10", "dose": "3.375g", "frequency": "q8h"},
                            {"renalCategory": "lt_10_no_hd", "additionalNotes": ["Refer to HD dosing"]},
                            {"renalCategory": "hd", "dose": "4.5g", "frequency": "q12h", "infusion": {"infuseMinutes": 30}},
                            {"renalCategory": "crrt", "dose": "4.5g", "frequency": "q8h", "infusion": {"infuseMinutes": 30}}
                          ]
                        }
                      ]
                    }
                  ]
                }
              ]
            },
            {
              "allergyProfile": ["pcn_severe_anaphylaxis"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [
                    {
                      "name": "aztreonam",
                      "routes": ["IV"],
                      "variants": [
                        {"label": "Serious systemic infections"}
                      ]
                    },
                    {
                      "name": "metronidazole",
                      "routes": ["IV", "PO"],
                      "variants": [
                        {"label": "C. difficile/CNS", "dose": "500mg", "frequency": "q8h"}
                      ]
                    },
                    {
                      "name": "vancomycin",
                      "routes": ["IV"],
                      "variants": [{
                        "label": "Standard Dosing",
                        "loadingDose": { "dose": "20-25 mg/kg" }
                      }]
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "label": "Healthcare Associated Intra-abdominal Infection",
          "eligibilityCriteria": {
            "setting": "Healthcare-Associated",
            "riskFlags": ["Recent IV antibiotics within 90 days", "Intra-abdominal surgery in the last year"]
          },
          "duration": {
            "minDays": 4,
            "maxDays": 4,
            "notes": [
              "Duration is 4 days after adequate source control."
            ]
          },
          "consults": [
            "ID consult recommended in patients who are hemodynamically unstable or have difficult to achieve source control."
          ],
          "treatmentRecommendations": [
            {
              "allergyProfile": ["none"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [{"name": "piperacillin-tazobactam"}],
                  "notes": ["Preferred option as provides coverage for Enterococcus faecalis."]
                },
                {
                  "rank": 2,
                  "primaryDrugs": [{"name": "cefepime"}, {"name": "metronidazole"}, {"name": "vancomycin"}]
                }
              ],
              "conditionalAdjuncts": [
                {
                  "condition": "History of ESBL, cephalosporin resistance, or septic shock",
                  "drugs": [{"name": "meropenem"}]
                },
                {
                  "condition": "Severe sepsis, septic shock, or history of VRE in past 12 months",
                  "drugs": [{"name": "daptomycin"}],
                  "notes": ["Replaces Vancomycin"]
                },
                {
                  "condition": "Severe sepsis or septic shock",
                  "drugs": [{"name": "micafungin"}]
                }
              ]
            },
            {
              "allergyProfile": ["pcn_mild_rash"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [{"name": "cefepime"}, {"name": "metronidazole"}, {"name": "vancomycin"}]
                }
              ],
               "conditionalAdjuncts": [
                {
                  "condition": "History of ESBL, cephalosporin resistance, or septic shock",
                  "drugs": [{"name": "meropenem"}]
                },
                {
                  "condition": "Severe sepsis, septic shock, or history of VRE in past 12 months",
                  "drugs": [{"name": "daptomycin"}],
                  "notes": ["Replaces Vancomycin"]
                },
                {
                  "condition": "Severe sepsis or septic shock",
                  "drugs": [{"name": "micafungin"}]
                }
              ]
            },
            {
              "allergyProfile": ["pcn_severe_anaphylaxis"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [{"name": "aztreonam"}, {"name": "metronidazole"}, {"name": "daptomycin"}],
                  "notes": ["Vancomycin may be used instead of Daptomycin. Consider Daptomycin if history of VRE, severe sepsis, or septic shock."]
                }
              ],
              "conditionalAdjuncts": [
                 {
                  "condition": "Severe sepsis or septic shock",
                  "drugs": [{"name": "micafungin"}]
                }
              ],
              "notes": ["If history of ESBL/septic shock, benefit of carbapenem should be weighed for IgE-mediated reactions; discuss with ID for SJS/DRESS."]
            }
          ]
        }
      ]
    }
  ]
}